Biosimilars NewsLatest News On Biosimilars What are biologics and why are they so expensive?11/13/2025 3:52 PM FDA Proposes Easing Rules for Cheaper Biologic Drug Alternatives10/29/2025 2:24 PM Volume, Not Price, Fueling Rise in Part D Specialty Derm Drug Spending7/18/2025 6:54 AM The Culprit Impeding Drug Competition Is Not Who The Feds Expected7/10/2025 8:59 AM Meet India’s Self-Made Biologics Brewmaster Billionaire5/26/2025 4:32 AM Dutch Court Case On Humira Assesses Whether Its Price Was `Excessive'5/9/2025 12:48 PM Biologic Overlap During Medication Switches Is Safe in IBD4/14/2025 5:40 AM FDA Approves Fourth Denosumab Biosimilar3/28/2025 2:40 AM Pharmacy Benefit Manager Reform Scuttled, Despite Bipartisan Support3/18/2025 8:44 AM Teva Pharma and Alvotech Launch Biosimilar to J&J's Stelara in US2/21/2025 12:53 PM
